Alliance Pharma acquires Perrigo scar treatments
Premium
28 March 2022
Alliance Pharma has accessed the OTC scar treatment market in the US by acquiring the ScarAway brand and US rights to Kelo-cote from Perrigo for USD19.4 million in cash.